[1]
|
Korfi K, Ali S, Heward JA, et al. Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations[J]. Epigenetics, 2017, 12(5):370-377. doi: 10.1080/15592294.2017.1282587
|
[2]
|
Ozawa MG, Bhaduri A, Chisholm KM, et al. A study of the mutational landscape of pediatric-type follicular lymphoma and pedaitric nodal marginal zone lymphoma[J]. Mod Pathol, 2016, 29(10):1212-1220. doi: 10.1038/modpathol.2016.102
|
[3]
|
Oschlies I, Salaverria I, Mahn F, et al. Pediatric follicular lymphomaa clinico-pathological study of a population-based series of patients treated within the non-hodgkin's lymphoma-berlin-frankfurtmunster(NHL-BFM) multicenter trials[J]. Haematologica, 2010, 95(2):253-259. doi: 10.3324/haematol.2009.013177
|
[4]
|
Louissaint A Jr, Ackerman AM, Dias-Santagata D, et al. Pediatrictype nodal follicular lymphoma:an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement[J]. Biood, 2012, 120(12):2395-2404.
|
[5]
|
Lorsbach RB, Dominic S, Jennifer M, et al. Clinicopathologic analysis of follicular lymphoma occuring in children[J]. Biood, 2002, 99(6):1959-1964.
|
[6]
|
Liu Q, Salaverria I, Pittaluga S, et al. Follicular lymphoma in children and young adults:A comparison of the pediatric variant with usual follicular lymphoma[J]. Am J Surg Pathol, 2013, 37(3):333-343. doi: 10.1097/PAS.0b013e31826b9b57
|
[7]
|
张帆, 刘银华, 焦南林, 等.儿童滤泡淋巴1例报道及文献复习[J].临床与实验病理学杂志, 2009, 25(1):49-53. doi: 10.3969/j.issn.1001-7399.2009.01.013
|
[8]
|
Swerdlow SH, Gampo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20):2375-2390. doi: 10.1182/blood-2016-01-643569
|
[9]
|
Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum[J]. Hematology Am Soc Hematol Educ Program, 2016, 2016(1):589-597. doi: 10.1182/asheducation-2016.1.589
|
[10]
|
Schmidt J, Gong S, Marafioti T, et al. Genome-wide analysis of pediatrictype follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene[J]. Blood, 2016, 128(8):1101-1111. doi: 10.1182/blood-2016-03-703819
|
[11]
|
Schmidt J, Ramis-Zaldivar JE, Nadeu F, et al. Mutationsof MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation[J]. Blood, 2017, 130(3):323-327. doi: 10.1182/blood-2017-03-776278
|
[12]
|
Louissaint A Jr, Schafernak KT, Geyer JT, et al. Pediatric-type nodal follicular lymphoma:a biologically distinct lymphoma with frequent MAPK pathway mutations[J]. Blood, 2016, 128(8):1093-1100. doi: 10.1182/blood-2015-12-682591
|
[13]
|
Green MR. Chromatin modifying gene mutations in follicular lymphoma[J]. Blood, 2018, 131(6):595-604. doi: 10.1182/blood-2017-08-737361
|
[14]
|
中华医学会血液学分会.中国滤泡性淋巴瘤诊断与治疗指南[J].中华血液学杂志, 2011, 32(10):717-720. doi: 10.3760/cma.j.issn.0253-2727.2011.10.022
|
[15]
|
Choi J, Choi HJ, Yim K, et al. Pediatric follicular lymphoma of the parotid gland[J]. Arch Craniofac Surg, 2018, 19(4):279-282. doi: 10.7181/acfs.2018.02075
|
[16]
|
Liams S, Rene B, Pennell N, et al. Prolonged molecular and cilnical remissions in follicular patients treated with HDT/ASCT and combination immunotherapy with rituximab and interferon[J]. Hematology Oncology, 2017, 35(14):365-366.
|
[17]
|
Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age sprctrum[J]. Hematology Am Soc Hematol Educ Program, 2016, 2016(1):589-597 doi: 10.1182/asheducation-2016.1.589
|